After three years in the making, Huntsville International is taking strides in improving storage for aircraft.
FDA clears United Therapeutics for human trials of pig-to-human kidney transplants. Trial involves gene-edited pig kidneys ...
After winning a breakthrough therapy designation for its Hunter syndrome enzyme replacement therapy, Denali Therapeutics is ...
United Therapeutics has scored a regulatory green light to start clinical trials for its genetically modified pig kidneys to ...
FDA aligned on single-arm Phase 3 study to support potential accelerated and full approvalOn track to dose first patient in Phase 3 trial in ...
Revisiting transfer 2½ years on, the mind boggles at how a deal in which United paid £30m above their price limit was sanctioned ...
BTIG analyst Julian Harrison maintained a Hold rating on United Therapeutics (UTHR – Research Report) on January 21. The company’s shares ...
View United Therapeutics Corporation (UTHR) current and estimated P/E ratio data provided by Seeking Alpha.
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
These companies valuations have fluctuated since - Exelixis' is now valued at $10.65bn, Genmab, $13.7bn, Alnylam, $32.4bn, BioMarin, $11.7bn, and United Therapeutics, $16.1bn, while Sarepta's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results